Search Count: 31
![]() |
Crystal Structure Of Gdp-Bound Kras G12D/M67R: Suppressing G12D Oncogenicity Via Second-Site M67R Mutation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-08 Classification: ONCOPROTEIN Ligands: GDP, MG |
![]() |
Crystal Structure Of Gdp-Bound Kras G12D/I55E: Suppressing G12D Oncogenicity Via Second-Site I55E Mutation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-08 Classification: ONCOPROTEIN Ligands: GDP, MG |
![]() |
Crystal Structure Of Gdp-Bound Kras G12D/F28K: Suppressing G12D Oncogenicity Via Second-Site F28K Mutation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-08 Classification: ONCOPROTEIN Ligands: GDP, MG, SO4 |
![]() |
Crystal Structure Of Gdp-Bound Kras G12D/P34R: Suppressing G12D Oncogenicity Via Second-Site P34R Mutation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-08 Classification: ONCOPROTEIN Ligands: MG, GDP |
![]() |
Crystal Structure Of Gdp-Bound Kras G12D/R41Q: Suppressing G12D Oncogenicity Via Second-Site R41Q Mutation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-08 Classification: ONCOPROTEIN Ligands: GDP, MG |
![]() |
Crystal Structure Of Gdp-Bound Kras G12D/V45E: Suppressing G12D Oncogenicity Via Second-Site V45E Mutation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-08 Classification: ONCOPROTEIN Ligands: GDP, MG |
![]() |
Crystal Structure Of Gdp-Bound Kras G12D/D54R: Suppressing G12D Oncogenicity Via Second-Site D54R Mutation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-08 Classification: ONCOPROTEIN Ligands: GDP, MG, SO4 |
![]() |
Crystal Structure Of Gdp-Bound Kras G12D/G60R: Suppressing G12D Oncogenicity Via Second-Site G60R Mutation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-08 Classification: ONCOPROTEIN Ligands: MG, GDP |
![]() |
Crystal Structure Of Gdp-Bound Kras G12D/V103Y: Suppressing G12D Oncogenicity Via Second-Site V103Y Mutation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-08 Classification: ONCOPROTEIN Ligands: MG, GDP |
![]() |
Crystal Structure Of Gdp-Bound Kras G12D/E62Q: Suppressing G12D Oncogenicity Via Second-Site E62Q Mutation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-08 Classification: ONCOPROTEIN Ligands: MG, GDP, SO4 |
![]() |
Crystal Structure Of Gdp-Bound Kras E3K/G12D: Suppressing G12D Oncogenicity Via Second-Site E3K Mutation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-08 Classification: ONCOPROTEIN Ligands: MG, GDP, GOL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: HYDROLASE Ligands: GNP, MG, CL, A1AZV |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: GNP, MG, A1AZX, CL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: GNP, MG, CL, A1AZY |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: GNP, MG, A1AZW |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: GNP, MG, CL, A1AZZ |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: SIGNALING PROTEIN Ligands: GNP, MG, CL, A1BEA, GOL |
![]() |
Crystal Structure At 3.4 Angstroms Resolution Of Maltodextrin Glucosidase, Malz, From Escherichia Coli
Organism: Escherichia coli (strain k12)
Method: X-RAY DIFFRACTION Resolution:3.30 Å Release Date: 2022-10-26 Classification: HYDROLASE Ligands: HOH |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2022-05-04 Classification: STRUCTURAL PROTEIN Ligands: MG, NO3 |
![]() |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2022-05-04 Classification: CELL CYCLE Ligands: GTP, MG, MN, CL |




















